| P04 | Newborn affected by noxious substances transmitted via placenta or breast milk |
| | Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery |
| | Newborn affected by other maternal medication |
| | Newborn affected by maternal antineoplastic chemotherapy |
| | Newborn affected by maternal cytotoxic drugs |
| | Newborn affected by maternal use of anticonvulsants |
| | Newborn affected by maternal use of opiates |
| | Newborn affected by maternal use of antidepressants |
| | Newborn affected by maternal use of amphetamines |
| | Newborn affected by maternal use of sedative-hypnotics |
| | Newborn affected by other maternal medication |
| | Newborn affected by maternal use of unspecified medication |
| | Newborn affected by maternal use of anxiolytics |
| | Newborn affected by maternal use of tobacco |
| | Newborn affected by maternal use of alcohol |
| | Newborn affected by maternal use of drugs of addiction |
| | Newborn affected by maternal use of unspecified drugs of addiction |
| | Newborn affected by maternal use of cocaine |
| | Newborn affected by maternal use of hallucinogens |
| | Newborn affected by maternal use of other drugs of addiction |
| | Newborn affected by maternal use of nutritional chemical substances |
| | Newborn affected by maternal exposure to environmental chemical substances |
| | Newborn affected by other maternal noxious substances |
| | Newborn affected by maternal use of cannabis |
| | Newborn affected by other maternal noxious substances |
| | Newborn affected by maternal noxious substance, unspecified |
